CAR-T cell therapy in triple-negative breast cancer: Hunting the invisible devil

Triple-negative breast cancer (TNBC) is known as the most intricate and hard-to-treat subtype of breast cancer. TNBC cells do not express the well-known estrogen receptor, progesterone receptor, and human epidermal growth factor receptor 2 (HER2) expressed by other breast cancer subtypes. This pheno...

Descripción completa

Detalles Bibliográficos
Autores principales: Nasiri, Fatemeh, Kazemi, Mehrasa, Mirarefin, Seyed Mohamad Javad, Mahboubi Kancha, Maral, Ahmadi Najafabadi, Milad, Salem, Faeze, Dashti Shokoohi, Setareh, Evazi Bakhshi, Sahar, Safarzadeh Kozani, Pouya, Safarzadeh Kozani, Pooria
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Immunology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9722775/
https://www.ncbi.nlm.nih.gov/pubmed/36483567
http://dx.doi.org/10.3389/fimmu.2022.1018786

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9722775/
https://www.ncbi.nlm.nih.gov/pubmed/36483567
http://dx.doi.org/10.3389/fimmu.2022.1018786

Ejemplares similares